{
    "clinical_study": {
        "@rank": "78745", 
        "acronym": "sildenafil", 
        "arm_group": [
            {
                "arm_group_label": "sildenafil", 
                "arm_group_type": "Experimental", 
                "description": "One  of  two  group  to  prepare  the  endometrium  give  estradiol  by  step  up  method  with   menstruation.\nFrom  first  to  fourth  day  of  menstrual  cycle,  estradiol  valerat  tablet  2 mg  daily From   Fifth  to  eighth  day  of  menstrual  cycle,  estradiol  valerat  tablet  4 mg  daily From  Ninth to twelfth day of menstrual ,  estradiol  valerat  tablet  6 mg  daily The  second  group  in  addition  to  the  above  treatment  protocol  from  First  day  of  cycle  until  day  of  starting  progesterone  will be given  sildenafil  tablets(50 mg)  daily."
            }, 
            {
                "arm_group_label": "Sildenafil and estradiol valerat", 
                "arm_group_type": "Experimental", 
                "description": "One  of  two  group  to  prepare  the  endometrium  give  estradiol  by  step  up  method  with   menstruation.\nFrom  first  to  fourth  day  of  menstrual  cycle,  estradiol  valerat  tablet  2 mg  daily From   Fifth  to  eighth  day  of  menstrual  cycle,  estradiol  valerat  tablet  4 mg  daily From  Ninth to twelfth day of menstrual ,  estradiol  valerat  tablet  6 mg  daily The  second  group  in  addition  to  the  above  treatment  protocol  from  First  day  of  cycle  until  day  of  starting  progesterone  will be given  sildenafil  tablets(50 mg)  daily."
            }
        ], 
        "brief_summary": {
            "textblock": "The  target  of  this  study  was  an  estimate  the  result  of  sildenafil  on\n      ultrasonographic  endometrial  thickness,  endometrial  pattern  investigation  estrogen\n      level  on  the  day  of  progesterone  administration,  Implantation rate  and  chemical\n      pregnancy  rate  in  frozen  embryo  transfer  cycles ."
        }, 
        "brief_title": "Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles", 
        "completion_date": {
            "#text": "February 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Endometrial Preparation", 
            "Frozen Embryo Transfer"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women > 40  years old,\n\n          -  history  of  endocrine  disease\n\n          -  Hysteroscopic  surgery\n\n          -  cardiovascular,  renal  and  liver  disease\n\n          -  hypotension(  blood  pressure < 90/50)\n\n          -  history  of  stroke  or  myocardial  infarction\n\n          -  use  of  alcohol or substance\n\n        Exclusion Criteria:\n\n        A  total  of  80  patients  with  antecedent  of  poor  endometrial  response  and  had\n        frozen  embryo  included  in  this  study all  women  must  to  be  < 40  years old,\n\n          -  no  history  of  endocrine  disease,\n\n          -  no  Hysteroscopic  surgery,  had  a  high  quality  embryos  no  cardiovascular,\n\n          -  renal  and  liver  disease  and\n\n          -  no hypotension (blood  pressure < 90/50)  or\n\n          -  history  of  stroke  or  myocardial  infarction  and\n\n          -  don't  use  of  alcohol or substance Patients  with  these  conditions  enter  this\n             study  and  based on randomized tables are divided in two groups."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "39 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "2", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01668446", 
            "org_study_id": "radvin123", 
            "secondary_id": [
                "rad123", 
                "rad123"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "sildenafil", 
                    "Sildenafil and estradiol valerat"
                ], 
                "description": "sildenafil  tablets(50 mg) daily", 
                "intervention_name": "Sildenafil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sildenafil and estradiol valerat", 
                "intervention_name": "estradiol valerat", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Estradiol", 
                "Polyestradiol phosphate", 
                "Estradiol valerate", 
                "Estradiol 3-benzoate", 
                "Estradiol 17 beta-cypionate", 
                "Sildenafil"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Sildenafil", 
            "Endometrial  thickness", 
            "Frozen  embryo  transfer", 
            "ultrasonographic  endometrial  thickness", 
            "endometrial  pattern", 
            "Implantation rate", 
            "chemical  pregnancy  rate"
        ], 
        "lastchanged_date": "September 11, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Yazd", 
                    "country": "Iran, Islamic Republic of", 
                    "zip": "8916878466"
                }, 
                "name": "Farzaneh Hojjat"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles", 
        "overall_official": {
            "affiliation": "Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Science, Bouali Ave. Safaieh, Yazd,Iran.", 
            "last_name": "farzaneh hojjat, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Assays:\nDay 13 of menstrual cycle endometrial thickness estimated with Transvaginal ultrasonographic(arranged in a series every other day), evaluations were performed by a single investigator, If the endometrial thickness is more than 8mm progesterone injected 100 mg intramuscular and Estrogen, progesterone and lh measured in blood sample then after three days embryo transferred.", 
            "measure": "estimate  the  result  of  sildenafil  on  ultrasonographic  endometrial  thickness", 
            "safety_issue": "Yes", 
            "time_frame": "between 2009-2011 (up to 2 years)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01668446"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shahid Sadoughi University of Medical Sciences and Health Services", 
            "investigator_full_name": "farzaneh hojjat", 
            "investigator_title": "Farzaneh hojjat MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Implantation  rate  was  higher  in  sildenafil  Group  but  not  significant chemical  pregnancy  rates  were  higher  in  sildenafil  Group  but  not  significant.", 
            "measure": "estimate  the  result  of  sildenafil  on Implantation rate  and  chemical  pregnancy  rate  in  frozen  embryo  transfer  cycles .", 
            "safety_issue": "Yes", 
            "time_frame": "between 2009-2011 (up to 2 years)"
        }, 
        "source": "Shahid Sadoughi University of Medical Sciences and Health Services", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Razieh dehghani firouzabadi", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Robab davar", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "farzaneh hojjat", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}